Welsis (OTC:WLSS) Stock, Quote.Headers.trade-ideas

Welsis Corp is a development-stage company formed to commence operations concerned with virtual psychological therapy that is also known as teletherapy or telepsychology services. The company provides counseling and psychological services for adolescents (from 14 years) and adults, for men and women, and therapy for individuals, couples, and families. It has a telehealth platform, delivering on-demand professional psychological consultations anytime, anywhere, via mobile devices, the internet, video, and phone calls. Its solution connects consumers with board-certified specialists.

Welsis Corp

News

VCIG

VCI Global Limited Announces The Development Of A Next-Generation AI Aggregator Platform. Designed to Streamline AI Integration

Chinese e-commerce giant&nbsp;JD.com, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JD#NASDAQ">JD</a>) shares are trading lower in the<a target="_blank" href="https://www.benzinga.com/premarket" rel="noreferrer noopener"> premarket session on Wednesday.</a>
The company is in the headlines today for reportedly reviving its interest in buying Düsseldorf, Germany-based Ceconomy AG, Bloomberg <a href="https://www.bloomberg.com/news/articles/2025-02-05/jd-com-is-said-to-revive-interest-in-buying-germany-s-ceconomy" target="_blank" rel="noreferrer noopener">reports</a>.
This is not the first time, when JD.com showed interest in the German retailer. Earlier in 2023, it expressed interest in Ceconomy.
According to&nbsp;<a target="_blank" href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw" rel="noreferrer noopener">Benzinga Pro</a>, JD has gained over 80% in the past year.
This time, JD.com is aiming for deal and has approached shareholders of the German company, Bloomberg adds, citing people familiar with the discussions.
Apart from the Ceconomy update, JD.com had been in the news last year for announcing in that it would not proceed with a previously considered cash offer for UK-based Currys.
See Also:&nbsp;<a target="_blank" href="https://www.benzinga.com/25/02/43480859/trump-confirms-maximum-economic-pressure-on-iran-calls-chinas-tariff-retaliation-fine" rel="noreferrer noopener">Trump Confirms Maximum Economic Pressure On Iran, Calls China's Tariff Retaliation ‘Fine'</a>
In a <a target="_blank" href="https://www.londonstockexchange.com/news-article/0JOQ/statement-from-jd-com/16380661" rel="noreferrer noopener">filing </a>to the London Stock Exchange, the company cited &#8220;careful&#8221; consideration as the reason behind its decision to back away from the transaction, after initially exploring the potential move in early 2024.
Meanwhile, JD.com&#8217;s relationship with Walmart has also evolved.
After eight years of partnership, Walmart Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WMT#NYSE">WMT</a>) last year sold its entire stake in JD.com, worth up to $3.74 billion, to refocus on its operations in China.
The two companies began their collaboration in 2016 when Walmart sold its Yihaodian grocery store to JD.com in exchange for a 5% stake, valued at around $1.5 billion at the time.
As JD.com explores its next moves, investors looking to gain exposure to the company can do so through the Invesco Golden Dragon China ETF (PGJ), which includes JD.com in its portfolio.
While JD.com&#8217;s stock has seen a slight dip in premarket trading, the company&#8217;s ongoing strategic shifts reflect its ambitious plans for growth and expansion in global markets.
Price Action: JD shares are trading lower by 2.84% to $40.14 premarket at last check Wednesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/02/43468887/robert-f-kennedy-nomination-advances-to-full-senate-vaccine-stocks-drop" target="_blank" rel="noreferrer noopener">Robert F. Kennedy's Health Secretary Nomination Advances To Full Senate: Vaccine Stocks Drop</a></li>
</ul>
Image: Shutterstock

Equities

Markets

Movers

General

JD.com's Stock Dips As Ceconomy Deal Heats Up In Germany: Is the E-Commerce King Eyeing Expansion?

Stephens &amp; Co. analyst Jim Salera maintains Lancaster Colony (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LANC#NASDAQ">LANC</a>) with a Equal-Weight and raises the price target from $196 to $200.

Price Target

Analyst Ratings

LANC

Stephens & Co. Maintains Equal-Weight on Lancaster Colony, Raises Price Target to $200

BWS Financial analyst Hamed Khorsand maintains Immersion (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IMMR#NASDAQ">IMMR</a>) with a Buy and maintains $13.5 price target.

IMMR

BWS Financial Maintains Buy on Immersion, Maintains $13.5 Price Target

XAIR

Beyond Air Receives Notification From Nasdaq Stating That The Company Has Been Granted An Additional 180-Day Compliance Period, Or Until August 4, 2025 To Regain Compliance With Nasdaq's Minimum Bid Price Rule

Baird analyst Andrew Wittmann maintains Jacobs Solutions (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/J#NYSE">J</a>) with a Outperform and lowers the price target from $154 to $148.

Baird Maintains Outperform on Jacobs Solutions, Lowers Price Target to $148

BWS Financial analyst Hamed Khorsand maintains A10 Networks (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ATEN#NYSE">ATEN</a>) with a Buy and maintains $24 price target.

ATEN

BWS Financial Maintains Buy on A10 Networks, Maintains $24 Price Target

WIIM

SMCI

Super Micro Computer shares are trading higher after the company announced the full production of NVIDIA Blackwell rack-scale solutions with NVIDIA HGX B200.

<a href="https://www.sec.gov/Archives/edgar/data/715153/000119312525020499/d878946d6k.htm" title="https://www.sec.gov/Archives/edgar/data/715153/000119312525020499/d878946d6k.htm">https://www.sec.gov/Archives/edgar/data/715153/000119312525020499/d878946d6k.htm</a>

NSANY

Honda Motor Reports On Integration Of Management Between Nissan Motor & Honda Says Nissan & Co Are In Stage Of Advancing Various Discussions

IVVD

Invivyd Announces A Strategic Partnership With Professional Football Coach Jim Harbaugh To Raise Awareness About the Ongoing Short And Potential Long-Term Risks of COVID-19 To The Broad Population

Baird analyst Ghansham Panjabi maintains Graphic Packaging Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GPK#NYSE">GPK</a>) with a Outperform and lowers the price target from $36 to $32.

Baird Maintains Outperform on Graphic Packaging Holding, Lowers Price Target to $32

Telsey Advisory Group analyst Dana Telsey maintains Capri Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CPRI#NYSE">CPRI</a>) with a Market Perform and maintains $23 price target.

CPRI

Telsey Advisory Group Maintains Market Perform on Capri Holdings, Maintains $23 Price Target

Canada-based global medical cannabis company&nbsp;Aurora Cannabis Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACB#NASDAQ">ACB</a>) reported a third-quarter fiscal 2025 net revenue of CA$88.2 million, compared to&nbsp;CA$64.4 <a target="_blank" href="https://www.benzinga.com/quote/ACB" rel="noreferrer noopener">million a year ago</a>.
The 37% increase from the prior period was mainly due to 51% growth in the global medical cannabis business and 22% in the plant propagation business, slightly offset by lower quarterly revenue in the <a target="_blank" href="https://www.benzinga.com/pressreleases/25/02/n43490408/aurora-cannabis-announces-fiscal-2025-third-quarter-results" rel="noreferrer noopener">consumer cannabis business</a>.
Consolidated adjusted gross margin was 65% in the third quarter and 53% in the prior-year quarter. Adjusted gross profit was&nbsp;CA$56.0 million&nbsp;in the third quarter vs.&nbsp;CA$33.6 million&nbsp;in the prior year quarter, an increase of 67%.
Also Read: <a target="_blank" href="https://www.benzinga.com/news/earnings/25/01/43195749/the-week-in-cannabis-trumps-dea-pick-tysons-reform-push-dutch-coffee-shop-crisis-and-more" rel="noreferrer noopener">The Week In Cannabis: Trump&#8217;s DEA Pick, Tyson&#8217;s Reform Push, Dutch Coffee Shop Crisis And More</a>
Medical cannabis net revenue was CA$68.1 million, a 51% increase from the prior-year quarter, driven by CA$23.1 million was primarily due to higher sales to Australia, Germany, Poland and the UK, as well as increased revenue in Canada to insurance covered and self-paying patients.
The adjusted gross margin reached 74%, compared to 63% in the prior year quarter, through sustainable cost reductions, higher selling prices, and improved efficiency in production operations, including sourcing for&nbsp;Europe&nbsp;from&nbsp;Canada.
Aurora&#8217;s consumer cannabis net revenue&nbsp;was&nbsp;CA$9.9 million, a 15% decrease compared to&nbsp;$11.6 million&nbsp;in the prior year quarter, mainly due to the decision to prioritize the supply of GMP manufactured products to high-margin global medical cannabis business rather than the consumer business, which offers lower margins.
Plant propagation net revenue contributed&nbsp;$8.9 million, a 22% increase compared to&nbsp;$7.3 million&nbsp;a year ago, due to organic growth and expanded product offerings arising from increased capacity.
Adjusted EBITDA&nbsp;increased 316% to&nbsp;CA$23.1 million&nbsp;compared to&nbsp;CA$5.5 million&nbsp;a year ago.
&#8220;This quarter was record-breaking for Aurora, driven by all-time highs in global medical net revenue, net income, adjusted EBITDA, and free cash flow,&#8221; said Miguel Martin, executive chairman and CEO for Aurora Cannabis.
Fiscal Q4 2025 Expectations:
<ul>
<li>Revenue is expected to grow, driven by international medical cannabis sales.</li>
<li>Seasonal increase in plant propagation revenue, following usual trends.</li>
<li>Strong profit margins and continued positive adjusted EBITDA.</li>
<li>Lower operating cash use due to disciplined spending and revenue growth.</li>
<li>Free cash flow should be slightly positive as cash use improves.</li>
</ul>
Price Action: ACB stock is up 31.3% at $4.83 during the premarket session at last check Wednesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/02/43491991/novo-nordisk-records-more-than-double-wegovy-sales-in-q4-seeks-regulatory-approval-for-hybrid-weight-loss-drug-in-2026" target="_blank" rel="noreferrer noopener">Novo Nordisk Q4 Earnings: Wegovy Sales More Than Double, Seeks Regulatory Approval For Hybrid Weight Loss Drug In 2026</a></li>
</ul>

Cannabis

Earnings

Guidance

Trading Ideas

Aurora Cannabis Stock Jumps On 'Record-Breaking' Q3 Earnings

BBAI

BigBear.Ai shares are trading higher after the company announced a contract by the DOD's chief digital and artificial intelligence office.

Baird analyst David Leiker maintains Cummins (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMI#NYSE">CMI</a>) with a Neutral and raises the price target from $395 to $407.

Baird Maintains Neutral on Cummins, Raises Price Target to $407

Beyond Air Granted 180-Day Extension To Regain Nasdaq Compliance

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>Baird raised Mercury Systems, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRCY#NASDAQ">MRCY</a>) price target from $37 to $58. Baird analyst Peter Arment upgraded the stock from Neutral to Outperform. Mercury Systems shares closed at $42.09 on Tuesday. <a href="https://www.benzinga.com/quote/MRCY/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Mizuho raised the price target for Hilton Worldwide Holdings Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HLT#NYSE">HLT</a>) from $243 to $263. Mizuho analyst Ben Chaiken downgraded the stock from Outperform to Neutral. Hilton Worldwide shares closed at $258.74 on Tuesday. <a href="https://www.benzinga.com/quote/HLT/analyst-ratings">See how other analysts view this stock.</a></li>
<li>DA Davidson cut The Clorox Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLX#NYSE">CLX</a>) price target from $171 to $169. DA Davidson analyst Linda Bolton Weiser maintained a Neutral rating. Clorox shares closed at $148.21 on Tuesday. <a href="https://www.benzinga.com/quote/CLX/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Needham raised the price target for Silicon Laboratories Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLAB#NASDAQ">SLAB</a>) from $140 to $150. Needham analyst Quinn Bolton maintained a Buy rating. Silicon Laboratories shares closed at $136.60 on Tuesday. <a href="https://www.benzinga.com/quote/SLAB/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Stephens &amp; Co. cut the price target for Chipotle Mexican Grill, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMG#NYSE">CMG</a>) from $61 to $60. Stephens &amp; Co. analyst Jim Salera maintained an Equal-Weight rating. Chipotle shares closed at $59.02 on Tuesday. <a href="https://www.benzinga.com/quote/CMG/analyst-ratings">See how other analysts view this stock.</a></li>
<li>JP Morgan raised Janus Henderson Group plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JHG#NYSE">JHG</a>) price target from $44 to $53. JP Morgan analyst Kenneth Worthington upgraded the stock from Neutral to Overweight. Janus Henderson shares settled at $44.02 on Tuesday. <a href="https://www.benzinga.com/quote/JHG/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Citigroup raised Molson Coors Beverage Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TAP#NYSE">TAP</a>) price target from $47 to $57. Citigroup analyst Filippo Falorni upgraded the stock from Sell to Neutral. Molson Coors shares closed at $52.95 on Tuesday. <a href="https://www.benzinga.com/quote/TAP/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Wells Fargo cut Snap Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNAP#NYSE">SNAP</a>) price target from $15 to $11. Wells Fargo analyst Ken Gawrelski downgraded the stock from Overweight to Equal-Weight. Snap shares closed at $11.60 on Tuesday.  <a href="https://www.benzinga.com/quote/SNAP/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Keybanc cut the price target for Advanced Micro Devices, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>) from $150 to $140. Keybanc analyst John Vinh maintained an Overweight rating. AMD shares settled at $119.50 on Tuesday. <a href="https://www.benzinga.com/quote/AMD/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Canaccord Genuity raised Spotify Technology S.A. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPOT#NYSE">SPOT</a>) price target from $650 to $700. Canaccord Genuity analyst Maria Ripps maintained a Buy rating. Spotify shares closed at $621.77 on Tuesday. <a href="https://www.benzinga.com/quote/SPOT/analyst-ratings">See how other analysts view this stock</a>.</li>
</ul>
Read This Next:
<ul>
<li> <a href="https://www.benzinga.com/trading-ideas/long-ideas/25/02/43460681/jim-cramer-says-no-to-bigbear-ai-recommends-buying-this-tech-stock">Jim Cramer Says No To BigBear.ai, Recommends Buying This Tech Stock</a></li>
</ul>

Janus Henderson Group plc Ordinary Shares

MRCY

SLAB

SNAP

SPOT

Spotify To Rally Around 13%? Here Are 10 Top Analyst Forecasts For Wednesday

Richmond FED President Barkin: Says There Are Jobs Out There That Had Been Devalued That Have Been Revalued Up Because Of Scarcity

Offerings

SXTP

60 Degrees Pharma Announces $1.075M Registered Direct Offering Of 1,503,500 Shares At $0.715/Share

Tech

MSFT

OpenAI Says Deep Research Now Rolled Out To 100% Of Pro Users

Welsis

Comments

Welsis

Welsis (WLSS) Forecast

Welsis (OTC:WLSS) Stock, Quote.Headers.trade-ideas

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga